Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-31falseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.Holding companytruefalsefalse2024-04-0122 13848715 2024-04-01 2025-03-31 13848715 2023-04-01 2024-03-31 13848715 2025-03-31 13848715 2024-03-31 13848715 c:Director1 2024-04-01 2025-03-31 13848715 d:CurrentFinancialInstruments 2025-03-31 13848715 d:CurrentFinancialInstruments 2024-03-31 13848715 d:Non-currentFinancialInstruments 2025-03-31 13848715 d:Non-currentFinancialInstruments 2024-03-31 13848715 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 13848715 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 13848715 d:Non-currentFinancialInstruments d:AfterOneYear 2025-03-31 13848715 d:Non-currentFinancialInstruments d:AfterOneYear 2024-03-31 13848715 d:ShareCapital 2025-03-31 13848715 d:ShareCapital 2024-03-31 13848715 d:RetainedEarningsAccumulatedLosses 2025-03-31 13848715 d:RetainedEarningsAccumulatedLosses 2024-03-31 13848715 c:FRS102 2024-04-01 2025-03-31 13848715 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 13848715 c:FullAccounts 2024-04-01 2025-03-31 13848715 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13848715 d:Subsidiary1 2024-04-01 2025-03-31 13848715 d:Subsidiary1 1 2024-04-01 2025-03-31 13848715 6 2024-04-01 2025-03-31 13848715 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Registered number: 13848715










PATIENT CARE HOLDING LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2025

 
PATIENT CARE HOLDING LIMITED
REGISTERED NUMBER: 13848715

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2025

2025
2024
Note
£
£

Fixed assets
  

Investments
 4 
1,853,623
1,853,623

  
1,853,623
1,853,623

  

Creditors: amounts falling due within one year
 5 
(909,720)
(852,649)

Net current liabilities
  
 
 
(909,720)
 
 
(852,649)

Total assets less current liabilities
  
943,903
1,000,974

Creditors: amounts falling due after more than one year
 6 
(939,796)
(989,878)

  

Net assets
  
4,107
11,096


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
4,007
10,996

  
4,107
11,096


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 16 December 2025.




Mr Gilbert Kamgang Nkuitche
Director

The notes on pages 3 to 6 form part of these financial statements.
Page 1

 
PATIENT CARE HOLDING LIMITED
REGISTERED NUMBER: 13848715
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2025


Page 2

 
PATIENT CARE HOLDING LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


General information

Patient Care Holding Limited is a private company, limited by share capital, incorporated in England and Wales under registration number 13848715. The address of the registered office is Level 5A, Maple House, 149 Tottenham Court Road, London, W1T 7NF.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.3

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each reporting date. Gains and losses on remeasurement are recognised in the Statement of comprehensive income for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

 
2.4

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.5

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.6

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 3

 
PATIENT CARE HOLDING LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2024 - 2).


4.


Fixed asset investments





Investments in subsidiary company

£



Cost or valuation


At 1 April 2024
1,853,623



At 31 March 2025
1,853,623




Page 4

 
PATIENT CARE HOLDING LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

Subsidiary undertaking


The following was a subsidiary undertaking of the Company:

Name

Principal activity

Class of shares

Holding

Patient Care Limited
Community pharmacy
Ordinary
100%

Page 5

 
PATIENT CARE HOLDING LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

5.


Creditors: Amounts falling due within one year

2025
2024
£
£

Bank loan
142,462
143,333

Other creditors
100,000
100,000

Amounts owed to subsidiary company
514,971
442,102

Directors' loan account
150,127
165,414

Accruals
2,160
1,800

909,720
852,649


Bank loan is secured by a fixed and floating charge over the assets of the company and personal guarantee of the directors.


6.


Creditors: Amounts falling due after more than one year

2025
2024
£
£

Bank loan
939,796
989,878

939,796
989,878


Bank loan is secured by a fixed and floating charge over the assets of the company and personal guarantee given by the directors.


7.


Controlling party

The company was under the control of Mr Gilbert Kamgang Nkuitche (50% share) and Mrs Chiara Fantuzzi (50% share) by virtue of the fact that between them they own 100% of the issued share capital of the company.

 
Page 6